Back

Answers in CME Inc. (AiCME)

  • Anemia
  • Myelodysplastic Syndromes

Answering Clinician Questions About Anemia in Lower-Risk Myelodysplastic Syndromes: Community-Based Strategies to Enhance Long-Term Efficacy

This enduring activity aims to strengthen community-based hematologists’ and hematology-oncologists’ ability to translate emerging clinical trial data into personalized, evidence-based treatment selection and sequencing strategies for anemia in lower-risk MDS. As a result of this educational activity, learners will be better able to: 1. Translate the latest clinical trial data to the management of patients with lower-risk MDS; 2. Evaluate evidence-based strategies for optimizing the use of available agents in lower-risk MDS; and 3. Design treatment plans that effectively sequence available therapies in patients with lower-risk MDS. Learners have access to downloadable materials for future use in clinical practice.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AMA PRA Category 1 Credit™Up to 0.5 credits

MOC types

No MOC

FDA REMS

No

Qualifies for MIPS

No

Pricing

Free

Reported to ACCME by the provider

  • Microlearning
  • Credit · Up to 0.5 credits
  • Commercial Support
  • Released
    Aug 17, 2026
  • Last day to claim credit
    Aug 17, 2027 10 months left